Passage Bio Ownership 2024 | Who Owns Passage Bio Now?
Institutional Ownership
67.18%
Insider Ownership
0.49%
Retail Ownership
32.33%
Institutional Holders
44.00
Passage Bio Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 17.98% | 0.16% | 10,124,576 | - | - | 8,040,938 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 10.75% | 0.36% | 6,052,000 | 1,552,000 | 34.49% | 4,806,498 | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 8.98% | 1.46% | 5,057,629 | 211,758 | 4.37% | 4,016,769 | Jun 30, 2024 |
| VERSANT VENTURE MANAGEMENT, LLC | 7.15% | 4.14% | 4,026,417 | -933,352 | -18.82% | 3,197,780 | Jun 30, 2024 |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 4.44% | 2.41% | 2,497,922 | - | - | 1,983,850 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.68% | - | 2,071,538 | - | - | 1,645,216 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.66% | 0.12% | 1,500,000 | - | - | 1,191,300 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.00% | 0.00% | 1,125,574 | -79,950 | -6.63% | 893,931 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.71% | 0.00% | 961,271 | - | - | 762,000 | Jun 30, 2024 |
| BLACKROCK INC. | 1.45% | - | 817,529 | -105,018 | -11.38% | 649,281 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.33% | 0.00% | 750,926 | -114,813 | -13.26% | 596,385 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.99% | 0.01% | 556,142 | - | - | 441,688 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.84% | 0.20% | 471,812 | 2,506 | 0.53% | 374,713 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.77% | - | 431,110 | 46,832 | 12.19% | 342,471 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.47% | 0.02% | 264,266 | - | - | 209,880 | Jun 30, 2024 |
| FIDUCIARY TRUST CO | 0.38% | 0.00% | 215,000 | - | - | 170,753 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.25% | 0.01% | 142,807 | - | - | 113,417 | Jun 30, 2024 |
| STATE STREET CORP | 0.22% | - | 123,873 | - | - | 98,380,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.18% | 0.00% | 103,854 | -97,299 | -48.37% | 82,481 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.15% | 0.01% | 85,500 | - | - | 67,905 | Jun 30, 2024 |
Passage Bio's largest institutional shareholder is ORBIMED ADVISORS LLC, holding 17.98% of the company's total share outstanding, currently valued at $8.04M. The top 10 institutional shareholders own together 60.81% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VERSANT VENTURE MANAGEMENT, LLC | 7.15% | 4.14% | 4,026,417 | -933,352 | -18.82% | 3,197,780 | Jun 30, 2024 |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 4.44% | 2.41% | 2,497,922 | - | - | 1,983,850 | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 8.98% | 1.46% | 5,057,629 | 211,758 | 4.37% | 4,016,769 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 10.75% | 0.36% | 6,052,000 | 1,552,000 | 34.49% | 4,806,498 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.84% | 0.20% | 471,812 | 2,506 | 0.53% | 374,713 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 17.98% | 0.16% | 10,124,576 | - | - | 8,040,938 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.66% | 0.12% | 1,500,000 | - | - | 1,191,300 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.47% | 0.02% | 264,266 | - | - | 209,880 | Jun 30, 2024 |
| DLK INVESTMENT MANAGEMENT, LLC | 0.11% | 0.02% | 64,000 | - | - | 50,829 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.15% | 0.01% | 85,500 | - | - | 67,905 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.99% | 0.01% | 556,142 | - | - | 441,688 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.25% | 0.01% | 142,807 | - | - | 113,417 | Jun 30, 2024 |
| FIDUCIARY TRUST CO | 0.38% | 0.00% | 215,000 | - | - | 170,753 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.71% | 0.00% | 961,271 | - | - | 762,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.00% | 0.00% | 1,125,574 | -79,950 | -6.63% | 893,931 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.03% | 0.00% | 17,039 | -25,924 | -60.34% | 13,532 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.33% | 0.00% | 750,926 | -114,813 | -13.26% | 596,385 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.18% | 0.00% | 103,854 | -97,299 | -48.37% | 82,481 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.02% | 0.00% | 13,203 | 13,169 | 38732.35% | 10,483 | Jun 30, 2024 |
| CRESSET ASSET MANAGEMENT, LLC | 0.04% | 0.00% | 23,725 | - | - | 18,842 | Jun 30, 2024 |
The largest Passage Bio shareholder by % of total assets is VERSANT VENTURE MANAGEMENT, LLC. The company owns 4.03M shares of Passage Bio (PASG), representing 4.14% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VESTAL POINT CAPITAL, LP | 10.75% | 0.36% | 6,052,000 | 1,552,000 | 34.49% | 4,806,498 | Jun 30, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 8.98% | 1.46% | 5,057,629 | 211,758 | 4.37% | 4,016,769 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.77% | - | 431,110 | 46,832 | 12.19% | 342,471 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.02% | 0.00% | 13,203 | 13,169 | 38732.35% | 10,483 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.84% | 0.20% | 471,812 | 2,506 | 0.53% | 374,713 | Jun 30, 2024 |
| UBS GROUP AG | 0.00% | - | 1,146 | 1,146 | 100.00% | 910 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | - | 400 | 400 | 100.00% | 318 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 367 | 366 | 36600.00% | 291 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.05% | - | 27,233 | 279 | 1.04% | 21,628 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 693 | 193 | 38.60% | 1,000 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | 0.00% | - | 60 | 60 | 100.00% | 48 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 4 | - | - | 4 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 273 | - | - | 217 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.00% | - | 47 | - | - | 37,000 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.00% | - | 783 | - | - | 621 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.00% | - | 783 | - | - | 622,000 | Jun 30, 2024 |
| BARCLAYS PLC | 0.02% | - | 13,153 | - | - | 10,000 | Jun 30, 2024 |
| STATE STREET CORP | 0.22% | - | 123,873 | - | - | 98,380,000 | Jun 30, 2024 |
| LRI INVESTMENTS, LLC | 0.00% | - | 225 | - | - | 179 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.68% | - | 2,071,538 | - | - | 1,645,216 | Jun 30, 2024 |
As of Jun 30 2024, Passage Bio's largest institutional buyer is VESTAL POINT CAPITAL, LP. The company purchased 1.55M stocks of PASG, valued at $4.81M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VERSANT VENTURE MANAGEMENT, LLC | 7.15% | 4.14% | 4,026,417 | -933,352 | -18.82% | 3,197,780 | Jun 30, 2024 |
| PALE FIRE CAPITAL SE | - | - | - | -141,435 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.33% | 0.00% | 750,926 | -114,813 | -13.26% | 596,385 | Jun 30, 2024 |
| BLACKROCK INC. | 1.45% | - | 817,529 | -105,018 | -11.38% | 649,281 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.18% | 0.00% | 103,854 | -97,299 | -48.37% | 82,481 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.00% | 0.00% | 1,125,574 | -79,950 | -6.63% | 893,931 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.03% | 0.00% | 17,039 | -25,924 | -60.34% | 13,532 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -25,425 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -21,990 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.11% | - | 64,512 | -19,755 | -23.44% | 51,235,000 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -11,290 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.02% | - | 13,442 | -395 | -2.85% | 10,676 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -309 | -100.00% | - | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.04% | - | 21,512 | -251 | -1.15% | 17,000 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -217 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 0.04% | - | 21,054 | -16 | -0.08% | 16,721 | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 4.44% | 2.41% | 2,497,922 | - | - | 1,983,850 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 17.98% | 0.16% | 10,124,576 | - | - | 8,040,938 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.66% | 0.12% | 1,500,000 | - | - | 1,191,300 | Jun 30, 2024 |
As of Jun 30 2024, Passage Bio's biggest institutional seller is VERSANT VENTURE MANAGEMENT, LLC. The company sold -0.93M shares of PASG, valued at $3.20M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GLOBAL RETIREMENT PARTNERS, LLC | 0.00% | - | 400 | 400 | 100.00% | 318 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | 0.00% | - | 60 | 60 | 100.00% | 48 | Jun 30, 2024 |
Passage Bio's largest new institutional shareholder by number of shares is GLOBAL RETIREMENT PARTNERS, LLC, purchased 400.00 shares, valued at $318.00, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PALE FIRE CAPITAL SE | - | - | - | -141,435 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -25,425 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -21,990 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -11,290 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -309 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -217 | -100.00% | - | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
Passage Bio's largest sold out institutional shareholder by shares sold is PALE FIRE CAPITAL SE, sold -0.14M shares, valued at -, as of undefined.
Passage Bio Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| CORNERCAP GROUP OF FUNDS /VA/ | 0.71% | 51,410 | 18,951 | 58.38% | Sep 30, 2022 |
| BRIDGEWAY FUNDS INC | 0.23% | 556,142 | 49,542 | 9.78% | Mar 28, 2024 |
| IndexIQ ETF Trust | 0.08% | 184,153 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 38,001 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.07% | 185,056 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.06% | 10,758 | - | - | Mar 28, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.04% | 316,659 | - | - | Jan 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.03% | 99,285 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.02% | 4,940 | - | - | Mar 31, 2024 |
| ACAP Strategic Fund | 0.02% | 238,499 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.02% | 23,317 | - | - | Jan 31, 2024 |
| FIDELITY CONTRAFUND | 0.01% | 893,722 | - | - | Mar 31, 2024 |
| ROYCE FUND | 0.01% | 84,000 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 59,966 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,678 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.01% | 147 | - | - | Dec 31, 2023 |
| MORGAN STANLEY INSTITUTIONAL FUND INC | 0.01% | 436,356 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 38,538 | - | - | Aug 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.01% | 43,581 | - | - | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.01% | 24,000 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 147,082 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 1,084 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,989,811 | -387,918 | -16.31% | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 31,897 | - | - | Jan 31, 2024 |
| North Square Investments Trust | 0.00% | 38,170 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.00% | 7,304 | - | - | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 51,410 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 192,822 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 38,538 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 21,054 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 304,240 | 3,927 | 1.31% | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 42,620 | - | - | Mar 31, 2024 |
| BNY MELLON FUNDS TRUST | 0.00% | 91,667 | - | - | Aug 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 156,900 | - | - | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 57,028 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,908 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 30,974 | - | - | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 18,274 | - | - | Dec 31, 2023 |
| FINANCIAL INVESTORS TRUST | 0.00% | 67,429 | - | - | Jan 31, 2024 |
| Federated Hermes Equity Funds | 0.00% | 16,000 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 97,619 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 32,574 | - | - | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 6,127 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 14,517 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 8,622 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,700 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 80,832 | - | - | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 161,429 | - | - | Feb 29, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 12,516 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 656 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 10,444 | - | - | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 112 | - | - | Apr 30, 2021 |
| SCHWAB CAPITAL TRUST | 0.00% | 7,891 | - | - | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 5,600 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 18,674 | - | - | Mar 28, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 128,826 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 7,000 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 8,451 | - | - | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 113,000 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 353 | - | - | Dec 31, 2023 |
| FIDELITY CAPITAL TRUST | 0.00% | 830 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 793 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 268,663 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 126,830 | - | - | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 5,820 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,249 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,600 | - | - | Mar 28, 2024 |
| FIDELITY SUMMER STREET TRUST | 0.00% | 19,677 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 9,869 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 196 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 13,747 | - | - | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 4,360 | - | - | Mar 28, 2024 |
| ALLSPRING FUNDS TRUST | 0.00% | 16,467 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,947 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 220 | - | - | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 1,245,751 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 36 | - | - | Dec 31, 2023 |
| ADVANCED SERIES TRUST | 0.00% | 99,949 | - | - | Mar 28, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 3,200 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 1,530 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 70,879 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 143,703 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 7,430 | - | - | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 8,137 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 4,581 | - | - | Feb 29, 2024 |
| FundVantage Trust | 0.00% | 274 | - | - | Mar 28, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,794 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 47,580 | - | - | Dec 31, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 1,729 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,516 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 31,700 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 10,730 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 240 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 4,090 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 772 | - | - | Feb 29, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 22,558 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 6,330 | -1,328 | -17.34% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 86,559 | -9,484 | -9.87% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 18,752 | - | - | Mar 31, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 1,460 | - | - | Dec 31, 2023 |
Passage Bio's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 51.41K shares, compromising 0.71% of its total assets.
Passage Bio Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 44 | -12.00% |
| 31 Mar, 24 | 50 | - |
| 31 Dec, 23 | 50 | 2.04% |
| 30 Sep, 23 | 49 | -9.26% |
| 30 Jun, 23 | 54 | -3.57% |
| 31 Mar, 23 | 56 | -13.85% |
| 31 Dec, 22 | 65 | -4.41% |
| 30 Sep, 22 | 68 | -13.92% |
| 30 Jun, 22 | 79 | -22.55% |
| 31 Mar, 22 | 102 | 3.03% |
| 31 Dec, 21 | 99 | -2.94% |
| 30 Sep, 21 | 102 | - |
| 30 Jun, 21 | 102 | 13.33% |
| 31 Mar, 21 | 90 | 26.76% |
| 31 Dec, 20 | 71 | 5.97% |
| 30 Sep, 20 | 67 | 1.52% |
| 30 Jun, 20 | 66 | 46.67% |
| 31 Mar, 20 | 45 | - |
As of 30 Jun 24, 44 institutions are holding Passage Bio's shares, representing a decrease of -12.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 37,821,661 | -0.07% |
| 31 Mar, 24 | 37,847,261 | 27.02% |
| 31 Dec, 23 | 29,797,319 | -0.77% |
| 30 Sep, 23 | 30,028,681 | -3.78% |
| 30 Jun, 23 | 31,206,832 | -8.17% |
| 31 Mar, 23 | 33,983,602 | -5.12% |
| 31 Dec, 22 | 35,816,274 | -6.35% |
| 30 Sep, 22 | 38,244,282 | -6.85% |
| 30 Jun, 22 | 41,058,526 | -2.14% |
| 31 Mar, 22 | 41,955,183 | -2.89% |
| 31 Dec, 21 | 43,203,667 | 2.67% |
| 30 Sep, 21 | 42,081,069 | -5.63% |
| 30 Jun, 21 | 44,592,591 | -0.90% |
| 31 Mar, 21 | 44,997,138 | 40.70% |
| 31 Dec, 20 | 31,980,467 | 3.92% |
| 30 Sep, 20 | 30,774,592 | -2.61% |
| 30 Jun, 20 | 31,599,027 | 8.39% |
| 31 Mar, 20 | 29,151,968 | - |
Passage Bio (PASG) has 37.82M shares outstanding as of 30 Jun 24, down -0.07% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 67.18% | 1.42% |
| 31 Mar, 24 | 68.88% | 2.33% |
| 31 Dec, 23 | 54.39% | 1.80% |
| 30 Sep, 23 | 54.91% | 1.68% |
| 30 Jun, 23 | 57.14% | 1.48% |
| 31 Mar, 23 | 62.22% | 1.44% |
| 31 Dec, 22 | 65.80% | 1.34% |
| 30 Sep, 22 | 70.21% | 1.23% |
| 30 Jun, 22 | 75.49% | 1.26% |
| 31 Mar, 22 | 77.30% | 1.18% |
| 31 Dec, 21 | 80.99% | 1.33% |
| 30 Sep, 21 | 77.93% | 1.14% |
| 30 Jun, 21 | 82.75% | 1.08% |
| 31 Mar, 21 | 87.66% | 1.78% |
| 31 Dec, 20 | 70.11% | 1.53% |
| 30 Sep, 20 | 67.63% | 1.40% |
| 30 Jun, 20 | 69.62% | 1.69% |
| 31 Mar, 20 | 64.23% | - |
As of 30 Jun 24, Passage Bio is held by 67.18% institutional shareholders, representing a 1.42% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 11 | -45.00% |
| 31 Mar, 24 | 20 | -4.76% |
| 31 Dec, 23 | 21 | 40.00% |
| 30 Sep, 23 | 15 | -6.25% |
| 30 Jun, 23 | 16 | -15.79% |
| 31 Mar, 23 | 19 | -24.00% |
| 31 Dec, 22 | 25 | 4.17% |
| 30 Sep, 22 | 24 | -29.41% |
| 30 Jun, 22 | 34 | -37.04% |
| 31 Mar, 22 | 54 | -6.90% |
| 31 Dec, 21 | 58 | 20.83% |
| 30 Sep, 21 | 48 | -23.81% |
| 30 Jun, 21 | 63 | 1.61% |
| 31 Mar, 21 | 62 | 31.91% |
| 31 Dec, 20 | 47 | 62.07% |
| 30 Sep, 20 | 29 | -30.95% |
| 30 Jun, 20 | 42 | -6.67% |
| 31 Mar, 20 | 45 | - |
11 institutional shareholders have increased their position in PASG stock as of 30 Jun 24 compared to 20 in the previous quarter (a -45.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 11 | -15.38% |
| 31 Mar, 24 | 13 | 30.00% |
| 31 Dec, 23 | 10 | -23.08% |
| 30 Sep, 23 | 13 | -27.78% |
| 30 Jun, 23 | 18 | 20.00% |
| 31 Mar, 23 | 15 | -34.78% |
| 31 Dec, 22 | 23 | -20.69% |
| 30 Sep, 22 | 29 | -14.71% |
| 30 Jun, 22 | 34 | 9.68% |
| 31 Mar, 22 | 31 | 40.91% |
| 31 Dec, 21 | 22 | -29.03% |
| 30 Sep, 21 | 31 | 82.35% |
| 30 Jun, 21 | 17 | 30.77% |
| 31 Mar, 21 | 13 | 18.18% |
| 31 Dec, 20 | 11 | -45.00% |
| 30 Sep, 20 | 20 | 53.85% |
| 30 Jun, 20 | 13 | - |
| 31 Mar, 20 | - | - |
11 institutional shareholders have reduced their position in PASG stock as of 30 Jun 24 compared to 13 in the previous quarter (a -15.38% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 44 | -12.00% | 37,821,661 | -0.07% | 67.18% | 1.42% | 11 | -45.00% | 11 | -15.38% |
| 31 Mar, 24 | 50 | - | 37,847,261 | 27.02% | 68.88% | 2.33% | 20 | -4.76% | 13 | 30.00% |
| 31 Dec, 23 | 50 | 2.04% | 29,797,319 | -0.77% | 54.39% | 1.80% | 21 | 40.00% | 10 | -23.08% |
| 30 Sep, 23 | 49 | -9.26% | 30,028,681 | -3.78% | 54.91% | 1.68% | 15 | -6.25% | 13 | -27.78% |
| 30 Jun, 23 | 54 | -3.57% | 31,206,832 | -8.17% | 57.14% | 1.48% | 16 | -15.79% | 18 | 20.00% |
| 31 Mar, 23 | 56 | -13.85% | 33,983,602 | -5.12% | 62.22% | 1.44% | 19 | -24.00% | 15 | -34.78% |
| 31 Dec, 22 | 65 | -4.41% | 35,816,274 | -6.35% | 65.80% | 1.34% | 25 | 4.17% | 23 | -20.69% |
| 30 Sep, 22 | 68 | -13.92% | 38,244,282 | -6.85% | 70.21% | 1.23% | 24 | -29.41% | 29 | -14.71% |
| 30 Jun, 22 | 79 | -22.55% | 41,058,526 | -2.14% | 75.49% | 1.26% | 34 | -37.04% | 34 | 9.68% |
| 31 Mar, 22 | 102 | 3.03% | 41,955,183 | -2.89% | 77.30% | 1.18% | 54 | -6.90% | 31 | 40.91% |
| 31 Dec, 21 | 99 | -2.94% | 43,203,667 | 2.67% | 80.99% | 1.33% | 58 | 20.83% | 22 | -29.03% |
| 30 Sep, 21 | 102 | - | 42,081,069 | -5.63% | 77.93% | 1.14% | 48 | -23.81% | 31 | 82.35% |
| 30 Jun, 21 | 102 | 13.33% | 44,592,591 | -0.90% | 82.75% | 1.08% | 63 | 1.61% | 17 | 30.77% |
| 31 Mar, 21 | 90 | 26.76% | 44,997,138 | 40.70% | 87.66% | 1.78% | 62 | 31.91% | 13 | 18.18% |
| 31 Dec, 20 | 71 | 5.97% | 31,980,467 | 3.92% | 70.11% | 1.53% | 47 | 62.07% | 11 | -45.00% |
| 30 Sep, 20 | 67 | 1.52% | 30,774,592 | -2.61% | 67.63% | 1.40% | 29 | -30.95% | 20 | 53.85% |
| 30 Jun, 20 | 66 | 46.67% | 31,599,027 | 8.39% | 69.62% | 1.69% | 42 | -6.67% | 13 | - |
| 31 Mar, 20 | 45 | - | 29,151,968 | - | 64.23% | - | 45 | - | - | - |
Passage Bio Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Passage Bio's stock was made by Borthwick Kathleen on Feb 13 2024, selling 1,470 shares at $0.97 per share (valued at $1.43K).
Passage Bio Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | 6 | - | - |
| Q1 2024 | 6 | 7 | 85.71% |
| Q4 2023 | 3 | 3 | 100.00% |
| Q3 2023 | 3 | 6 | 50.00% |
| Q2 2023 | 11 | 4 | 275.00% |
| Q1 2023 | 5 | - | - |
| Q4 2022 | 6 | 3 | 200.00% |
| Q3 2022 | 2 | 2 | 100.00% |
| Q2 2022 | 29 | - | - |
| Q1 2022 | 17 | - | - |
| Q4 2021 | 1 | 2 | 50.00% |
| Q3 2021 | 4 | - | - |
| Q2 2021 | 11 | 2 | 550.00% |
| Q1 2021 | 12 | 4 | 300.00% |
| Q1 2020 | 49 | 37 | 132.43% |
0 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Passage Bio's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | 5 | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | 2 | 2 | 100.00% |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 2 | - |
| Q3 2022 | - | 1 | - |
| Q2 2022 | 3 | - | - |
| Q1 2022 | 9 | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 2 | - | - |
| Q1 2021 | - | 4 | - |
| Q1 2020 | 19 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Passage Bio's stocks.
PASG Ownership FAQ
Who Owns Passage Bio?
Passage Bio is owned by institutional shareholders (67.18%), insiders (0.49%), and public (32.33%). The largest institutional shareholder of Passage Bio is ORBIMED ADVISORS LLC (17.98% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (0.71% of total shares).
Who are the major institutional shareholders of Passage Bio?
Passage Bio's major institutional shareholders are ORBIMED ADVISORS LLC, VESTAL POINT CAPITAL, LP, LYNX1 CAPITAL MANAGEMENT LP, VERSANT VENTURE MANAGEMENT, LLC, and NEW LEAF VENTURE PARTNERS, L.L.C.. The top five shareholders own together 49.31% of the company's share outstanding.
How many Passage Bio shareholders are there?
As of Jun 2024, there are 44 institutional shareholders of Passage Bio.
What percentage of Passage Bio is owned by ORBIMED ADVISORS LLC?
ORBIMED ADVISORS LLC owns 10.12M shares of Passage Bio, representing 17.98% of the company's total shares outstanding, valued at $8.04M (as of Jun 2024).
What percentage of Passage Bio is owned by VESTAL POINT CAPITAL, LP?
As of Jun 2024, VESTAL POINT CAPITAL, LP holds 6.05M shares of Passage Bio (PASG), compromising 10.75% of the company, valued at $4.81M.
What percentage of Passage Bio is owned by LYNX1 CAPITAL MANAGEMENT LP?
LYNX1 CAPITAL MANAGEMENT LP is the third largest holder of Passage Bio. The company owns 5.06M of the company's shares outstanding (worth $4.02M).